Reuters logo
BRIEF-Gemphire Therapeutics announces $12.5 mln financing - SEC Filing
March 10, 2017 / 3:53 PM / 6 months ago

BRIEF-Gemphire Therapeutics announces $12.5 mln financing - SEC Filing

March 10 (Reuters) - Gemphire Therapeutics Inc :

* Entered into securities purchase agreement for private placement with “a select group of accredited investors” - SEC Filing

* Private placement will consist of 1.3 million units sold at price of $9.47 per unit for gross proceeds of about $12.5 million

* Intends to fund development costs, phase 2 clinical trial of gemcabene, manufacturing related activities for gemcabene Source text: (bit.ly/2lL4Pkx) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below